EG-018

Also Known As:

Naphthalen-1-yl(9-pentyl-9h-carbazol-3-yl)methanone

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Hypothermia 01/01/2020 - "Following intravenous (i.v.) administration, EG-018 (56 mg/kg) produced hypomotility, catalepsy, and hypothermia, but only catalepsy was blocked by the selective CB1 antagonist rimonabant (3 mg/kg, i.v.). "
2.	Catalepsy 01/01/2020 - "Following intravenous (i.v.) administration, EG-018 (56 mg/kg) produced hypomotility, catalepsy, and hypothermia, but only catalepsy was blocked by the selective CB1 antagonist rimonabant (3 mg/kg, i.v.). "

1.	Rimonabant